{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04640532",
            "orgStudyIdInfo": {
                "id": "KRT-232-113"
            },
            "organization": {
                "fullName": "Kartos Therapeutics, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "KRT-232 in Combination With TL-895 for the Treatment of R/R MF and KRT-232 for the Treatment of JAKi Intolerant MF",
            "officialTitle": "An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 in Combination With TL-895 for the Treatment of Relapsed or Refractory Myelofibrosis and KRT-232 for the Treatment of JAK Inhibitor Intolerant Myelofibrosis.",
            "therapeuticArea": [
                "Other"
            ],
            "study": "krt-in-combination-with-tl-for-the-treatment-of-r-r-mf-and-krt-for-the-treatment-of-jaki-intolerant-mf"
        },
        "statusModule": {
            "statusVerifiedDate": "2022-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2020-11-17",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2022-05-11",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-07-24",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-11-17",
            "studyFirstSubmitQcDate": "2020-11-17",
            "studyFirstPostDateStruct": {
                "date": "2020-11-23",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2022-05-05",
            "lastUpdatePostDateStruct": {
                "date": "2022-05-09",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Kartos Therapeutics, Inc.",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "Telios Pharma, Inc.",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study evaluates KRT-232 in Combination With TL-895 for the Treatment of Relapsed or Refractory Myelofibrosis and KRT-232 for the Treatment of JAK Inhibitor Intolerant Myelofibrosis.",
            "detailedDescription": "Cohorts 1 and 2 will undergo dose finding and dose expansion. Eligible patients will be randomly assigned to an open cohort, either Cohort 1 or Cohort 2. Cohort 3 will be conducted as a dose expansion, independent of Cohorts 1 and 2.\n\nCohort 1 will follow a 3+3 dose escalation design to determine the maximum tolerated dose (MTD)/maximum administered dose (MAD) and recommended Phase 2 dose (RP2D) of TL-895 administered QD in combination with KRT-232. A Safety Review Committee (SRC) will review the safety data during the dose escalation to decide on dose escalation and/or exploration of intermediate doses.\n\nCohort 2 will follow a 3+3 dose escalation design to determine the MTD/MAD and recommended RP2D of TL-895 administered BID in combination with KRT-232. An SRC will review the safety data during the dose escalation to decide on dose escalation and/or exploration of intermediate doses.\n\nCohort 3 will be conducted a 2-stage design. In stage 1, enrollment will continue until 15 evaluable patients have been enrolled. An SRC will review the data during the study and if there are \u22654 responders based on the futility criteria and safety data from Stage 1, Cohort 3 expansion will commence. If there are \u22643 patients responding to therapy, Cohort 3 will be terminated. Once expansion criteria have been met, Cohort 3 will be expanded to a total of 46 evaluable patients for Stage 2 analyses."
        },
        "conditionsModule": {
            "conditions": [
                "Myelofibrosis",
                "Post-PV MF",
                "Post-ET Myelofibrosis",
                "Primary Myelofibrosis"
            ],
            "keywords": [
                "Relapsed/Refractory Myelofibrosis",
                "Janus associated Kinase Inhibitor-Intolerant Myelofibrosis",
                "MDM2",
                "navtemadlin"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 116,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Cohort 1 (R/R MF), Dose Level 1",
                    "type": "EXPERIMENTAL",
                    "description": "TL-895 at 200 mg once a day (QD) continuously starting on Cycle 1 Day 1 in a 28-day cycle.\n\nKRT-232 240mg will be administered orally, once daily (QD), on days 1-7 in a 28-day cycle starting on Cycle 2 Day 1.",
                    "interventionNames": [
                        "Drug: KRT-232",
                        "Drug: TL-895"
                    ]
                },
                {
                    "label": "Cohort 1 (R/R MF), Dose Level 2",
                    "type": "EXPERIMENTAL",
                    "description": "TL-895 at 300 mg once a day (QD) continuously starting on Cycle 1 Day 1 in a 28-day cycle.\n\nKRT-232 at 240mg will be administered orally, once daily (QD), on days 1-7 in a 28-day cycle starting on Cycle 2 Day 1.",
                    "interventionNames": [
                        "Drug: KRT-232",
                        "Drug: TL-895"
                    ]
                },
                {
                    "label": "Cohort 2 (R/R MF), Dose Level 1",
                    "type": "EXPERIMENTAL",
                    "description": "TL-895 at 100 mg twice a day (BID) continuously starting on Cycle 1 Day 1 in a 28-day cycle.\n\nKRT-232 at 240mg will be administered orally, once daily (QD), on days 1-7 in a 28-day cycle starting on Cycle 2 Day 1.",
                    "interventionNames": [
                        "Drug: KRT-232",
                        "Drug: TL-895"
                    ]
                },
                {
                    "label": "Cohort 2 (R/R MF), Dose Level 2",
                    "type": "EXPERIMENTAL",
                    "description": "TL-895 at 150 mg twice a day (BID) continuously starting on Cycle 1 Day 1 in a 28-day cycle.\n\nKRT-232 at 240mg will be administered orally, once daily (QD), on days 1-7 in a 28-day cycle starting on Cycle 2 Day 1.",
                    "interventionNames": [
                        "Drug: KRT-232",
                        "Drug: TL-895"
                    ]
                },
                {
                    "label": "Cohort 3 (JAKi Intolerant MF)",
                    "type": "EXPERIMENTAL",
                    "description": "KRT-232 at 240mg will be administered orally, once daily (QD), on days 1-7 in a 28-day cycle.",
                    "interventionNames": [
                        "Drug: KRT-232"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "KRT-232",
                    "description": "KRT-232, administered by mouth",
                    "armGroupLabels": [
                        "Cohort 1 (R/R MF), Dose Level 1",
                        "Cohort 1 (R/R MF), Dose Level 2",
                        "Cohort 2 (R/R MF), Dose Level 1",
                        "Cohort 2 (R/R MF), Dose Level 2",
                        "Cohort 3 (JAKi Intolerant MF)"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "TL-895",
                    "description": "TL-895, administered by mouth",
                    "armGroupLabels": [
                        "Cohort 1 (R/R MF), Dose Level 1",
                        "Cohort 1 (R/R MF), Dose Level 2",
                        "Cohort 2 (R/R MF), Dose Level 1",
                        "Cohort 2 (R/R MF), Dose Level 2"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Phase 1b - The MTD/MAD and RP2D of TL-895 in combination with KRT-232 in patients with R/R MF (Cohort 1 and Cohort 2)",
                    "description": "DLTs will be used to establish the MTD. RP2D will be determined by the SRC based on safety data from the combination of TL-895 and KRT-232.",
                    "timeFrame": "56 Days"
                },
                {
                    "measure": "Phase 2 - Spleen response rate for each cohort",
                    "description": "A reduction in spleen volume as assessed by MRI (or CT) \u2265 35% from baseline at Week 24",
                    "timeFrame": "24 Weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Total Symptom Score (TSS)",
                    "description": "The change in TSS based Myelofibrosis Symptom Assessment Form version 4.0 (MFSAF v4.0)",
                    "timeFrame": "24 Weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Confirmed diagnosis of primary MF, post-PV MF, or post-ET MF, (WHO 2016)\n* ECOG \u2264 2\n* Cohort 1 and Cohort 2: R/R following JAK inhibitor treatment\n* Cohort 3: patients who are intolerant to JAK inhibitor treatment\n\nExclusion Criteria:\n\n* Prior treatment with MDM2 inhibitors or p53-directed therapies\n* Prior treatment with a BCR-ABL, phosphoinositide 3-kinase (PI3k), mammalian target of rapamycin (mTOR), bromodomain and extraterminal domain (BET), histone deacetylase (HDAC), or spleen tyrosine kinase (Syk) inhibitor\n* Prior splenectomy\n* Splenic irradiation within 3 months prior to the first dose of study treatment\n* Clinically significant thrombosis within 3 months of screening\n* Grade 2 or higher QTc prolongation",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "John Mei",
                    "role": "CONTACT",
                    "phone": "650-542-0136",
                    "email": "jmei@kartosthera.com"
                },
                {
                    "name": "Irene Dea",
                    "role": "CONTACT",
                    "phone": "(650) 839-7341",
                    "email": "idea@kartosthera.com"
                }
            ],
            "locations": [
                {
                    "facility": "University of Alabama at Birmingham School of Medicine, Division of Hematology and Oncology",
                    "status": "RECRUITING",
                    "city": "Birmingham",
                    "state": "Alabama",
                    "zip": "35233",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.52066,
                        "lon": -86.80249
                    }
                },
                {
                    "facility": "The Oncology Institute of Hope",
                    "status": "RECRUITING",
                    "city": "Whittier",
                    "state": "California",
                    "zip": "90603",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.97918,
                        "lon": -118.03284
                    }
                },
                {
                    "facility": "Lake City Cancer Center",
                    "status": "RECRUITING",
                    "city": "Lake City",
                    "state": "Florida",
                    "zip": "32024",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 30.18968,
                        "lon": -82.63929
                    }
                },
                {
                    "facility": "Carle Cancer Center",
                    "status": "RECRUITING",
                    "city": "Urbana",
                    "state": "Illinois",
                    "zip": "61801",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.11059,
                        "lon": -88.20727
                    }
                },
                {
                    "facility": "Columbia University Medical Center",
                    "status": "RECRUITING",
                    "city": "Fort Lee",
                    "state": "New Jersey",
                    "zip": "07024",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.85093,
                        "lon": -73.97014
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Cancer Center (MSKCC)",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "LKH Hochsteiermark",
                    "status": "RECRUITING",
                    "city": "Leoben",
                    "zip": "8700",
                    "country": "Austria",
                    "geoPoint": {
                        "lat": 47.3765,
                        "lon": 15.09144
                    }
                },
                {
                    "facility": "Meduni Wien, Univ. Klinik f\u00fcr Innere Medizin I",
                    "status": "RECRUITING",
                    "city": "Wien",
                    "zip": "1090",
                    "country": "Austria",
                    "geoPoint": {
                        "lat": 48.20849,
                        "lon": 16.37208
                    }
                },
                {
                    "facility": "University Multiprofile Hospital for Active Treatment Dr. Georgi Stranski, Pleven",
                    "status": "RECRUITING",
                    "city": "Pleven",
                    "zip": "5800",
                    "country": "Bulgaria",
                    "geoPoint": {
                        "lat": 43.41667,
                        "lon": 24.61667
                    }
                },
                {
                    "facility": "University Multiprofile Hospital for Active Treatment Dr. Georgi Plovdiv",
                    "status": "RECRUITING",
                    "city": "Plovdiv",
                    "zip": "4002",
                    "country": "Bulgaria",
                    "geoPoint": {
                        "lat": 42.15,
                        "lon": 24.75
                    }
                },
                {
                    "facility": "Hematology Clinic Specialized Hospital for Active Treatment of Hematological Diseases, Sofia",
                    "status": "RECRUITING",
                    "city": "Sofia",
                    "zip": "1756",
                    "country": "Bulgaria",
                    "geoPoint": {
                        "lat": 42.69751,
                        "lon": 23.32415
                    }
                },
                {
                    "facility": "Chu Amiens Picardie Site Sud",
                    "status": "RECRUITING",
                    "city": "Amiens",
                    "zip": "80054",
                    "country": "France",
                    "geoPoint": {
                        "lat": 49.9,
                        "lon": 2.3
                    }
                },
                {
                    "facility": "CHU de Limoges Service H\u00e9matologie Clinique et Th\u00e9rapie Cellulaire",
                    "status": "RECRUITING",
                    "city": "Limoges",
                    "zip": "87042",
                    "country": "France",
                    "geoPoint": {
                        "lat": 45.83153,
                        "lon": 1.25781
                    }
                },
                {
                    "facility": "CHU Nantes - H\u00f4tel Dieu",
                    "status": "RECRUITING",
                    "city": "Nantes",
                    "zip": "44093",
                    "country": "France",
                    "geoPoint": {
                        "lat": 47.21725,
                        "lon": -1.55336
                    }
                },
                {
                    "facility": "CHU de Nice Hospital",
                    "status": "RECRUITING",
                    "city": "Nice",
                    "zip": "06200",
                    "country": "France",
                    "geoPoint": {
                        "lat": 43.70313,
                        "lon": 7.26608
                    }
                },
                {
                    "facility": "H\u00f4pital Saint Louis",
                    "status": "RECRUITING",
                    "city": "Paris",
                    "zip": "75475",
                    "country": "France",
                    "geoPoint": {
                        "lat": 48.85341,
                        "lon": 2.3488
                    }
                },
                {
                    "facility": "Centre Hospitalier Lyon Sud",
                    "status": "RECRUITING",
                    "city": "Pierre-B\u00e9nite",
                    "zip": "63310",
                    "country": "France",
                    "geoPoint": {
                        "lat": 45.7009,
                        "lon": 4.82511
                    }
                },
                {
                    "facility": "University Hospital Halle (Saale), Department of Internal Medicine IV - Hematology and Oncology",
                    "status": "RECRUITING",
                    "city": "Halle",
                    "zip": "06120",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 51.48159,
                        "lon": 11.97948
                    }
                },
                {
                    "facility": "University Hospital Marburg, Department of Hematology, Oncology and Immunology",
                    "status": "RECRUITING",
                    "city": "Marburg",
                    "zip": "35043",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 50.80904,
                        "lon": 8.77069
                    }
                },
                {
                    "facility": "Moritz Kaposi General Hospital, Department of Hematology",
                    "status": "RECRUITING",
                    "city": "Kaposv\u00e1r",
                    "zip": "H-7400",
                    "country": "Hungary",
                    "geoPoint": {
                        "lat": 46.36667,
                        "lon": 17.8
                    }
                },
                {
                    "facility": "Szabolcs-Szatmar-Bereg County Hospitals and University Teaching Hospital, Department of Hematology",
                    "status": "RECRUITING",
                    "city": "Ny\u00edregyh\u00e1za",
                    "zip": "H-4400",
                    "country": "Hungary",
                    "geoPoint": {
                        "lat": 47.95539,
                        "lon": 21.71671
                    }
                },
                {
                    "facility": "Medical Center of the University of Pecs, 1st Department of Internal Medicine, Division of Hematology",
                    "status": "RECRUITING",
                    "city": "P\u00e9cs",
                    "zip": "H-7624",
                    "country": "Hungary",
                    "geoPoint": {
                        "lat": 46.08333,
                        "lon": 18.23333
                    }
                },
                {
                    "facility": "Fejer County St. Gyorgy University Teaching Hospital, Department of Internal Medicine III, Hematology",
                    "status": "RECRUITING",
                    "city": "Sz\u00e9kesfeh\u00e9rv\u00e1r",
                    "zip": "H-8000",
                    "country": "Hungary",
                    "geoPoint": {
                        "lat": 47.18995,
                        "lon": 18.41034
                    }
                },
                {
                    "facility": "Polyclinic S. Orsola-Malpighi",
                    "status": "RECRUITING",
                    "city": "Bologna",
                    "zip": "40138",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 44.49381,
                        "lon": 11.33875
                    }
                },
                {
                    "facility": "ASST Spedali Civili di Brescia",
                    "status": "RECRUITING",
                    "city": "Brescia",
                    "zip": "25123",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.53558,
                        "lon": 10.21472
                    }
                },
                {
                    "facility": "Careggi University Hospital",
                    "status": "RECRUITING",
                    "city": "Florence",
                    "zip": "50134",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 43.77925,
                        "lon": 11.24626
                    }
                },
                {
                    "facility": "Hospital Casa Sollievo della Sofferenza, Department of Oncology and Hematology, Division of Hematology",
                    "status": "RECRUITING",
                    "city": "Foggia",
                    "zip": "71013",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 41.45845,
                        "lon": 15.55188
                    }
                },
                {
                    "facility": "Hospital of Ravenna, Operative Unit of Hematology",
                    "status": "RECRUITING",
                    "city": "Ravenna",
                    "zip": "48121",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 44.41344,
                        "lon": 12.20121
                    }
                },
                {
                    "facility": "Jan Biziel University Hospital #2 in Bydgoszcz, Department of Hematology",
                    "status": "RECRUITING",
                    "city": "Bydgoszcz",
                    "zip": "85-168",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 53.1235,
                        "lon": 18.00762
                    }
                },
                {
                    "facility": "Pratia Onkologia Katowice",
                    "status": "RECRUITING",
                    "city": "Katowice",
                    "zip": "40-519",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 50.25841,
                        "lon": 19.02754
                    }
                },
                {
                    "facility": "Frederic Chopin Provincial Teaching Hospital No. 1 in Rzeszow, Department of Hematology",
                    "status": "RECRUITING",
                    "city": "Rzesz\u00f3w",
                    "zip": "35-055",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 50.04132,
                        "lon": 21.99901
                    }
                },
                {
                    "facility": "Slupsk Provincial Specialist Hospital n.a. Janusz Korczak, Department of Hematology",
                    "status": "RECRUITING",
                    "city": "S\u0142upsk",
                    "zip": "76-200",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 54.46405,
                        "lon": 17.02872
                    }
                },
                {
                    "facility": "Nasz Lekarz Medical Outpatient Clinics Slawomir Jeka",
                    "status": "RECRUITING",
                    "city": "Toru\u0144",
                    "zip": "87-100",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 53.01375,
                        "lon": 18.59814
                    }
                },
                {
                    "facility": "Clinical Center of Serbia",
                    "status": "RECRUITING",
                    "city": "Belgrade",
                    "zip": "11000",
                    "country": "Serbia",
                    "geoPoint": {
                        "lat": 44.80401,
                        "lon": 20.46513
                    }
                },
                {
                    "facility": "Clinical Center of Vojvodina",
                    "status": "RECRUITING",
                    "city": "Novi Sad",
                    "zip": "21000",
                    "country": "Serbia",
                    "geoPoint": {
                        "lat": 45.25167,
                        "lon": 19.83694
                    }
                },
                {
                    "facility": "Hematologia Cl\u00ednica",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "zip": "08003",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "University Clinical Hospital of Salamanca, Department of Hematology",
                    "status": "RECRUITING",
                    "city": "Salamanca",
                    "zip": "37007",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.96882,
                        "lon": -5.66388
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000055728",
                    "term": "Primary Myelofibrosis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009196",
                    "term": "Myeloproliferative Disorders"
                },
                {
                    "id": "D000001855",
                    "term": "Bone Marrow Diseases"
                },
                {
                    "id": "D000006402",
                    "term": "Hematologic Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M28312",
                    "name": "Primary Myelofibrosis",
                    "asFound": "Myelofibrosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12149",
                    "name": "Myeloproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M5134",
                    "name": "Bone Marrow Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9490",
                    "name": "Hematologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T4705",
                    "name": "Primary Myelofibrosis",
                    "asFound": "Myelofibrosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1311",
                    "name": "Chronic Myeloproliferative Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M1474",
                    "name": "Janus Kinase Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}